Value Marijuana Companies Grow with GW Pharma Double
Mentor Capital, Inc. (OTCQB:MNTR) announced that Mentor’s Cannabis Index
for Value Investors has gained 22% YTD during 2016. According to Mentor
CEO, Chet Billingsley, “The index was boosted by GW Pharmaceuticals'
(NASDAQ:GWPH) recent doubling after its cannabidiol drug for childhood
epilepsy received a positive nod from the FDA.” The other leaders
reported by Mentor in its marijuana index were indoor cultivation system
experts Surna, Inc., (OTCQB:SRNA) at (326%) and new cannabis patent
participant Mentor Capital at (354%), when compared to NASDAQ average
unit sales, book value and growth set together at (100%).
“Because legal marijuana sales growth is largely a political
reclassification from illegal to legal it is not surprising that there
is great interest in the political changes this election cycle will
bring within the cannabis operating and investment community.
Speculations abound from Donald Trump coopting the youth vote and weeks
of air time by backing legalization once he is past the primaries, to
President Obama declassifying marijuana off of Schedule 1 as a swansong
during his last days. Regardless, the political mode is for greater
legalization. That momentum seems to support the observed growth in the
legal cannabis market, and the index, at about 400% of the growth of
NASDAQ,” reports the Mentor Capital CEO.
The other cannabis stocks and their respective ratios to NASDAQ in this
value focused marijuana stock index are: Americann, Inc. (OTCQX:ACAN) at
(58%); Digipath, Inc. (OTCQB:DIGP) at (162%); GW Pharmacueticals, Plc at
(135%); Hemp, Inc. (OTCMkts:HEMP) at (98%), and Terra Tech Corp
(OTCQX:TRTC) at (87%). The complete Index can be found at: www.MentorCapital.com.
About Mentor Capital: The Company seeks to come alongside and
assist private medical marijuana and cannabis companies and their
founders in meeting their liquidity and financial objectives, to add
protection for investors and to help incubate private cannabis companies.
This press release is neither an offer to sell, nor a solicitation of
offers to purchase, securities.
Forward Looking Statements: This press release contains
forward-looking statements within the meaning of the federal securities
laws, including statements concerning financial projections, financing
activities, corporate combinations, product development activities and
sales and licensing activities. Such forward-looking statements
are not guarantees of future results or performance, are sometimes
identified by words of condition such as “should,” “could,” “expects,”
“may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject
to a number of risks and uncertainties, known and unknown, that could
cause actual results to differ materially from those intended or
anticipated. Such risks include, without limitation:
nonperformance of investments, partner and portfolio difficulties,
potential delays in marketing and sales, problems securing the necessary
financing to continue operations, problems involving continued
illegality of cannabis products, potential of competitive
products, services, and technologies, difficulties experienced in
product development, in recruiting knowledgeable personnel and in
protecting intellectual property. Further information concerning
these and other risks is included in the Company’s 10-K and 10-Q filings
including the Company’s most recent Quarterly Report on Form 10-Q for
the quarter ended September 30, 2015 which, along with other very
important information about the Company, can be found filed with the SEC
and here:
http://mentorcapital.com/disclosures/
The Company undertakes no obligation to update or revise such
forward-looking statements to reflect new information, events or
circumstances occurring after the date of this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160321005474/en/
Copyright Business Wire 2016